Literature DB >> 2333834

Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity.

J J Gleysteen1, J J Barboriak, E A Sasse.   

Abstract

Lipids and clinical changes including diabetes and hypertension were monitored in morbidly obese patients after Roux-Y gastric bypass. Total cholesterol (Chol), high-density-lipoprotein (HDL) cholesterol, and triglycerides at 1 and at 5-7 y postoperatively in 33 patients and at 1 y in 23 patients (including apolipoproteins A-I and B) were compared with preoperative concentrations. Mean concentrations of Chol and both apolipoproteins were unchanged. Elevated serum triglycerides became normal, and reduced concentrations persisted at 5-7 y in men (p less than 0.025). HDL-cholesterol concentrations increased at 1 y (p less than 0.01) and remained higher at 5-7 y in women. Ratios of Chol to HDL cholesterol were lower at 1 y (p less than 0.01) in both men and women. Diabetes (9 patients) and hypertension (22 patients) also were reduced at 1 y (p less than 0.01) and remained lower at 5-7 y. A mean 61% of excess weight was lost in 1 y whereas a 12% weight gain occurred by 5-7 y. The beneficial changes in most coronary risk factors lasted 5-7 y after surgery.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2333834     DOI: 10.1093/ajcn/51.5.774

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  11 in total

1.  The impact of hospital and surgeon volume on clinical outcome following bariatric surgery.

Authors:  Sheraz R Markar; Marta Penna; Alan Karthikesalingam; Majid Hashemi
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

2.  The big fat bariatric bandwagon.

Authors:  J H Pinkney; A B Johnson; E A M Gale
Journal:  Diabetologia       Date:  2010-09       Impact factor: 10.122

3.  National trends in utilization and outcomes of bariatric surgery.

Authors:  T L Trus; G D Pope; S R G Finlayson
Journal:  Surg Endosc       Date:  2005-03-11       Impact factor: 4.584

Review 4.  Impact of gastrointestinal surgery on cardiometabolic risk.

Authors:  Fady Moustarah; Audrée Gilbert; Jean-Pierre Després; André Tchernof
Journal:  Curr Atheroscler Rep       Date:  2012-12       Impact factor: 5.113

Review 5.  Bariatric surgery: prevalence, predictors, and mechanisms of diabetes remission.

Authors:  George Argyropoulos
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

6.  Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity.

Authors:  R E Brolin; L J Bradley; A C Wilson; R P Cody
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

7.  Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients.

Authors:  Nicolas V Christou; John S Sampalis; Moishe Liberman; Didier Look; Stephane Auger; Alexander P H McLean; Lloyd D MacLean
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

8.  Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery.

Authors:  David Arterburn; Daniel P Schauer; Ruth E Wise; Keith S Gersin; David R Fischer; Calvin A Selwyn; Anne Erisman; Joel Tsevat
Journal:  Obes Surg       Date:  2008-08-13       Impact factor: 4.129

9.  Changes in lipid profile and insulin resistance in obese patients after Scopinaro biliopancreatic diversion.

Authors:  Magdalena Vila; Olga Ruíz; Mar Belmonte; Maria Riesco; Antonia Barceló; Gerardo Perez; Jose Moreiro; Ramon Salinas
Journal:  Obes Surg       Date:  2009-01-06       Impact factor: 4.129

10.  Apolipoprotein A-IV, a putative satiety/antiatherogenic factor, rises after gastric bypass.

Authors:  Derek M Culnan; Robert N Cooney; Bruce Stanley; Christopher J Lynch
Journal:  Obesity (Silver Spring)       Date:  2008-10-23       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.